Special populations: vulnerability and protection - DOI: 10.3395/reciis.v2.Sup1.207en

by Wendy Rogers, Angela Ballantyne
Published 2008-12-01

Points of contention: Qualitative research identifying where researchers and research ethics committees disagree about consent waivers for secondary research with tissue and data.

by Angela Ballantyne, Andrew Moore, Karen Bartholomew, Nic Aagaard
Published 2020-01-01

Equity in vaccine trials for higher weight people? Protocol for a rapid review of inclusion and exclusion criteria for higher weight people in clinical trials for COVID-19

by Angela Ballantyne, Anita Heywood, Matthew Hobbs, Lesley Gray, Jessica Campbell, Lily O’Hara
Published 2021-06-01

“Who is watching the watchdog?”: ethical perspectives of sharing health-related data for precision medicine in Singapore

by Tamra Lysaght, Angela Ballantyne, Vicki Xafis, Serene Ong, Gerald Owen Schaefer, Jeffrey Min Than Ling, Ainsley J. Newson, Ing Wei Khor, E. Shyong Tai
Published 2020-11-01

Trust and Trade-Offs in Sharing Data for Precision Medicine: A National Survey of Singapore

by Tamra Lysaght, Angela Ballantyne, Hui Jin Toh, Andrew Lau, Serene Ong, Owen Schaefer, Makoto Shiraishi, Willem van den Boom, Vicki Xafis, E Shyong Tai
Published 2021-09-01

3-Fluorobenzoic acid–4-acetylpyridine (1/1) at 100 K

by Andrew Parkin, Chick C. Wilson, Alex Whyte, Neil Thomson, Graeme Stewart, Duncan J. Sneddon, Harriet Saxby, Jenna Quail, Sarah Palmer, Alan R. G. Martin, Robert McTaggart, Eve McCalmont, Clifford Harris, Gary Copeland, Stephen C. Cairns, Andrew Cairns, Angela Ballantyne, Martin S. Adam, Lynne H. Thomas, Gavin A. Craig
Published 2009-02-01